BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34032649)

  • 21. Developmental perspectives in pediatric psychopharmacology.
    Vitiello B; Jensen PS
    Psychopharmacol Bull; 1995; 31(1):75-81. PubMed ID: 7675993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interest of pharmacoepidemiology for the study of psychotropic drugs.
    Tournier M; Montastruc F
    Therapie; 2019 Apr; 74(2):239-244. PubMed ID: 30792080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potential role for the gut microbiome in substance use disorders.
    Meckel KR; Kiraly DD
    Psychopharmacology (Berl); 2019 May; 236(5):1513-1530. PubMed ID: 30982128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basic principles of therapy with neuropsychotropic drugs].
    Gründer G; Veselinović T; Paulzen M
    Nervenarzt; 2012 Sep; 83(9):1193-208. PubMed ID: 22955719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management.
    Flowers SA; Ellingrod VL
    Pharmacotherapy; 2015 Oct; 35(10):910-6. PubMed ID: 26497477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review.
    Kloosterboer SM; Vierhout D; Stojanova J; Egberts KM; Gerlach M; Dieleman GC; Hillegers MHJ; Passe KM; Gelder TV; Dierckx B; Koch BCP
    Expert Opin Drug Saf; 2020 Jul; 19(7):873-890. PubMed ID: 32421365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury.
    Hammond FM; Barrett RS; Shea T; Seel RT; McAlister TW; Kaelin D; Ryser DK; Corrigan JD; Cullen N; Horn SD
    Arch Phys Med Rehabil; 2015 Aug; 96(8 Suppl):S256-3.e14. PubMed ID: 26212402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotropic medications and HIV.
    Thompson A; Silverman B; Dzeng L; Treisman G
    Clin Infect Dis; 2006 May; 42(9):1305-10. PubMed ID: 16586391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
    Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
    Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine.
    Crettol S; de Leon J; Hiemke C; Eap CB
    Clin Pharmacol Ther; 2014 Mar; 95(3):254-7. PubMed ID: 24196844
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
    Kanner AM; Gidal BE
    Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gut microbiome in psychiatry: A primer for clinicians.
    Van Ameringen M; Turna J; Patterson B; Pipe A; Mao RQ; Anglin R; Surette MG
    Depress Anxiety; 2019 Nov; 36(11):1004-1025. PubMed ID: 31356715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex.
    Marazziti D; Baroni S; Picchetti M; Piccinni A; Carlini M; Vatteroni E; Falaschi V; Lombardi A; Dell'Osso L
    CNS Spectr; 2013 Jun; 18(3):118-27. PubMed ID: 23374978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avoiding psychotropic drug interactions in the cardiovascular patient.
    DeVane CL; Markowitz JS
    Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confounder or Confederate? The Interactions Between Drugs and the Gut Microbiome in Psychiatric and Neurological Diseases.
    Michaelis L; Berg L; Maier L
    Biol Psychiatry; 2024 Feb; 95(4):361-369. PubMed ID: 37331548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in pharmacologic management of the hospitalized patient with psychiatric comorbidity.
    Ward M; Schwartz A
    J Hosp Med; 2013 Sep; 8(9):523-9. PubMed ID: 23913579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of ethanol and smoking on the pharmacokinetics and pharmacodynamics of psychotropic medications.
    Shoaf SE; Linnoila M
    Psychopharmacol Bull; 1991; 27(4):577-94. PubMed ID: 1813903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry.
    Kato TA; Yamauchi Y; Horikawa H; Monji A; Mizoguchi Y; Seki Y; Hayakawa K; Utsumi H; Kanba S
    Curr Med Chem; 2013; 20(3):331-44. PubMed ID: 23157624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.